119-hr238

[Congressional Bills 119th Congress]
[From the U.S. Government Publishing Office]
[H.R. 238 Introduced in House

    (IH) ]

<DOC>

119th CONGRESS
 1st Session
 H. R. 238

 To amend the Federal Food, Drug, and Cosmetic Act to clarify that 
 artificial intelligence and machine learning technologies can qualify 
 as a practitioner eligible to prescribe drugs if authorized by the 
 State involved and approved, cleared, or authorized by the Food and 
 Drug Administration, and for other purposes.

_______________________________________________________________________

 IN THE HOUSE OF REPRESENTATIVES

 January 7, 2025

Mr. Schweikert introduced the following bill; which was referred to the 
 Committee on Energy and Commerce

_______________________________________________________________________

 A BILL

 To amend the Federal Food, Drug, and Cosmetic Act to clarify that 
 artificial intelligence and machine learning technologies can qualify 
 as a practitioner eligible to prescribe drugs if authorized by the 
 State involved and approved, cleared, or authorized by the Food and 
 Drug Administration, and for other purposes.

 Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

 This Act may be cited as the ``Healthy Technology Act of 2025''.

SEC. 2. PRESCRIPTION OF DRUGS BY ARTIFICIAL INTELLIGENCE OR MACHINE 
 LEARNING TECHNOLOGIES.

 

Section 503

    (b) of Federal Food, Drug, and Cosmetic Act (21 U.S.C. 
353

    (b) ) is amended by adding at the end the following:
 ``

    (6) In this subsection, the term `practitioner licensed by law to 
administer such drug' includes artificial intelligence and machine 
learning technology that are--
 ``
        (A) authorized pursuant to a statute of the State 
 involved to prescribe the drug involved; and
 ``
        (B) approved, cleared, or authorized under 

section 510

    (k) , 513, 515, or 564.''.
 <all>